Concepedia

Kathryn D. Lasseter

KD

Statistics

Publications

5

Citations

232

H-Index

5

Active since

2019

Affiliations

Brigham and Women's Hospital(Current)

Dana-Farber Cancer Institute

Istituti di Ricovero e Cura a Carattere Scientifico

The University of Queensland

GenomeScan (Netherlands)

Kathryn D. Lasseter is an author at Brigham and Women's Hospital specializing in medicine, pathology, and tumor heterogeneity.

Top concepts

Publications per year

2019–2023

5

Publications

5

TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study

Barbara Ogórek, Lana Hamieh, Hanna M. Hulshof et al. · Genetics in Medicine · 2020 · 86 citations · Full text

, , +10

Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma

Kathryn D. Lasseter, Amin H. Nassar, Lana Hamieh et al. · Genetics in Medicine · 2020 · 65 citations

, , +10

Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission

Krinio Giannikou, Kathryn D. Lasseter, Joannes M. Grevelink et al. · Genetics in Medicine · 2019 · 57 citations · Full text

Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

Amin H. Nassar, Lana Hamieh, Kathryn P. Gray et al. · Molecular Cancer Therapeutics · 2019 · 13 citations · Full text

Molecular EPISTOP, a comprehensive multi-omic analysis of blood from Tuberous Sclerosis Complex infants age birth to two years

Franz Huschner, Jagoda Głowacka‐Walas, James D. Mills et al. · Nature Communications · 2023 · 11 citations · Full text

Rows per page

1–5 of 5